COVID-19 vaccine effectiveness in patients with non–dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada

[1]  A. Garg,et al.  Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada , 2022, Journal of the American Society of Nephrology : JASN.

[2]  F. Diekmann,et al.  Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients , 2022, Journal of Nephrology.

[3]  A. Butt,et al.  Real-world Effectiveness of the SARS-CoV-2 mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  F. Tentori,et al.  Comparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector–Based Ad26.COV2.S Vaccine for the Prevention of COVID-19 among Dialysis Patients , 2022, Journal of the American Society of Nephrology : JASN.

[5]  S. Bell,et al.  The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland , 2022, medRxiv.

[6]  F. Tentori,et al.  Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis , 2021, Journal of the American Society of Nephrology : JASN.

[7]  C. Ghossein,et al.  Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.